May 22, 2000 - 424B3: Prospectus filed pursuant to Rule 424(b)(3) | Huntington Bancshares Incorporated (HBAN) :: Huntington Bancshares Incorporated (HBAN)

PRICING SUPPLEMENT

Pricing Supplement No. 9 Filing Under Rule 424 (b) (3)
Dated: May 15, 2000 Registration File No. 33-63175

(To Prospectus dated October 6, 1995 and
Prospectus Supplement dated October 17, 1995)

CUSIP No. 44615QAV9

$750,000,000

HUNTINGTON BANCSHARES INCORPORATED

MEDIUM TERM NOTES, SERIES B

Principal Amount: $25,000,000 Floating Rate Notes:
Interest Rate (if fixed rate): N/A Interest Rate Basis: 3-month LIBOR
Stated Maturity: May 22, 2001 Index Maturity: Quarterly
Minimum denominations: $100,000 Spread: N/A
Issue Price (as a percentage Spread Multiplier: N/A
of principal amount): Variable Maximum Rate: N/A
Selling Agent's commission (%): 0.015 Minimum Rate: N/A
Purchasing Agent's discount Initial Interest Rate: 6.81875%
or commission (%): N/A Interest Reset Date(s): Each Interest Payment Date
Net proceeds to the Company: $24,996,250 Interest Reset Period: Quarterly
Settlement date (original issue date): May 22, 2000 Interest Determination Date(s): A/S
Redemption Commencement Date (if any): N/A Calculation Date(s): A/S
Initial Redemption Percentage (if any): N/A Interest Payment Date(s): August 22, 2000
Annual Redemption Percentage November 22, 2000; February 22, 2001;
Reduction (if any): N/A May 22, 2001
Repayment Date (if any): N/A Interest Payment Period(s): Quarterly
Initial Repayment Percentage (if any): N/A Regular Record Date(s): A/S
Annual Repayment Percentage
Reduction (if any): N/A

Additional terms: Interest will be computed on the basis of the actual number of
days in the year divided by 360.

As of the date of this Pricing Supplement, the aggregate initial public
offering price of the Debt Securities (as defined in the Prospectus) which have
been sold (including the Notes to which this Pricing Supplement relates) is
$315,000,000.

"N/A" as used herein means "Not Applicable". "A/S" as used herein means "as
stated in the Prospectus Supplement referred to above".

Chase Securities Inc.